BACKGROUND: Nearly 40% of patients requiring a hematopoietic stem cell transplant lack a suitable donor. However, virtually all these patients have a potential family donor with whom they share one HLA haplotype. METHODS: We report the rationale for making hematopoietic stem cell transplantation from haploidentical related donors feasible, as well as the method followed to achieve this. Two studies are reported, designed to overcome the problem of rejection and graft-versus-host disease after haploidentical stem cell transplantation. We describe how our total body irradiation-based, highly immuno- and myelosuppressive conditioning regimens were developed and how they have been modified over the years in an attempt to improve the clinical...
INTRODUCTION There are many indications for hematopoietic stem cell transplantation. In addition to ...
PURPOSE: Establishment of hematopoietic stem-cell (HSC) transplantation from mismatched relatives i...
Hematopoietic stem cell transplantation (HSCT) from HLA haploidentical mismatched donors has recentl...
BACKGROUND AND PURPOSE: To evaluate the efficacy and toxicity of a highly immuno- and myelo-suppres...
BACKGROUND: In this study we tried to achieve successful transplantation in patients with acute leu...
Much progress has been made in the clinical, biological and technical aspects of the T-cell-depleted...
In high-risk acute leukemia patients, a 10-fold increase in the dose of extensively T-cell-depleted ...
Despite the advent of targeted therapies and novel agents, allogeneic hematopoietic stem cell transp...
Much progress has been made in the clinical, biological and technical aspects of the T-cell-depleted...
For patients with high-risk acute leukemia who do not have a matched donor or who urgently need a tr...
Haploidentical stem cell transplantation is a treatment option for the approximately 70 % of patient...
Over the last 4 decades, allogeneic hematopoietic stem cell transplantation (allo-HSCT) from an HLA-...
Hematopoietic stem cell transplantation from haploidentical donors is an attractive method of transp...
AbstractHaploidentical hematopoietic stem cell transplantation (HSCT) provides an opportunity for ne...
Much progress has been made in the clinical, biological and technical aspects of the T-cell-depleted...
INTRODUCTION There are many indications for hematopoietic stem cell transplantation. In addition to ...
PURPOSE: Establishment of hematopoietic stem-cell (HSC) transplantation from mismatched relatives i...
Hematopoietic stem cell transplantation (HSCT) from HLA haploidentical mismatched donors has recentl...
BACKGROUND AND PURPOSE: To evaluate the efficacy and toxicity of a highly immuno- and myelo-suppres...
BACKGROUND: In this study we tried to achieve successful transplantation in patients with acute leu...
Much progress has been made in the clinical, biological and technical aspects of the T-cell-depleted...
In high-risk acute leukemia patients, a 10-fold increase in the dose of extensively T-cell-depleted ...
Despite the advent of targeted therapies and novel agents, allogeneic hematopoietic stem cell transp...
Much progress has been made in the clinical, biological and technical aspects of the T-cell-depleted...
For patients with high-risk acute leukemia who do not have a matched donor or who urgently need a tr...
Haploidentical stem cell transplantation is a treatment option for the approximately 70 % of patient...
Over the last 4 decades, allogeneic hematopoietic stem cell transplantation (allo-HSCT) from an HLA-...
Hematopoietic stem cell transplantation from haploidentical donors is an attractive method of transp...
AbstractHaploidentical hematopoietic stem cell transplantation (HSCT) provides an opportunity for ne...
Much progress has been made in the clinical, biological and technical aspects of the T-cell-depleted...
INTRODUCTION There are many indications for hematopoietic stem cell transplantation. In addition to ...
PURPOSE: Establishment of hematopoietic stem-cell (HSC) transplantation from mismatched relatives i...
Hematopoietic stem cell transplantation (HSCT) from HLA haploidentical mismatched donors has recentl...